Streetbeat News

ASC

Ardmore Shipping Corporation

Industry

Marine Shipping

Ardmore Shipping Corporation engages in the seaborne transportation of petroleum products and chemicals worldwide. As of February 15, 2022, the company operated a fleet of 25 double-hulled product and chemical tankers. It serves oil majors, oil companies, oil and chemical traders, chemical companies, and pooling service providers. The company was founded in 2010 and is based in Pembroke, Bermuda.

Open

11.00

Mkt cap

469M

Volume

643K

High

11.24

P/E Ratio

3.16

52-wk high

23.44

Low

10.87

Div yield

0.10

52-wk low

10.86

Ardmore Shipping Corporation (ASC) is gaining attention from investors, as noted by Zacks.com users. This suggests potential interest in the stock's future performance.

Portfolio Pulse from

December 16, 2024 | 3:15 pm

Wall Street analysts are optimistic about Ardmore Shipping (ASC), which could influence investor decisions and impact the stock's price.

Portfolio Pulse from

December 11, 2024 | 3:45 pm

Ardmore Shipping Corporation (ASC) is gaining attention from investors on Zacks.com. It's important to consider the factors that could influence its stock performance.

Portfolio Pulse from

December 03, 2024 | 3:15 pm

Wall Street analysts have given positive recommendations for Ardmore Shipping (ASC), suggesting it as a good investment. Analyst ratings can influence stock prices, but their importance varies.

Portfolio Pulse from

November 25, 2024 | 3:45 pm

Investors are showing increased interest in Ardmore Shipping Corporation (ASC), as evidenced by the high search activity on Zacks.com. This suggests a growing curiosity or concern about the company's stock performance.

Portfolio Pulse from

November 22, 2024 | 3:15 pm

ZyVersa Therapeutics has published a peer-reviewed study showing that its inflammasome ASC inhibitor, IC 100, can protect against stroke-related cardiovascular injury and dysfunction in preclinical trials. The study highlights the potential of IC 100 in blocking AIM2 inflammasome activation in the heart.

Portfolio Pulse from

November 20, 2024 | 1:15 pm

Ardmore Shipping has been upgraded due to its appealing valuation, massive discount, and attractive yield. The company reported higher revenue, EBITDA, and EPS in Q3 compared to Q3 2023. Ardmore holds $47.6 million in cash and has a Total Debt-to-Equity ratio of 8.1%.

Portfolio Pulse from

November 19, 2024 | 7:30 am

Ascletis Pharma has completed enrollment for a Phase III trial of ASC40, a once-daily oral tablet for treating moderate to severe acne. The trial includes 480 patients, with results expected in Q2 2025.

Portfolio Pulse from

November 12, 2024 | 11:45 am

Ardmore Shipping Corporation (ASC) is gaining attention from investors, as noted by Zacks.com users. This suggests potential interest in the stock's future performance.

Portfolio Pulse from

November 11, 2024 | 3:15 pm

Ardmore Shipping (ASC) is being considered a good investment by Wall Street analysts. The article questions the impact of these analyst recommendations on stock prices.

Portfolio Pulse from

November 07, 2024 | 3:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.